Galmed Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update

Go back to Galmed Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update

Galmed Pharma (GLMD) Misses Q2 EPS by 4c

August 3, 2016 8:51 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q2 EPS of ($0.39), $0.04 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More